-
Injured Bayern starlet Karl to miss Real return leg
-
US-Iran talks in Pakistan uncertain as sides trade accusations
-
Oil spill snarls shipping traffic in Antwerp port
-
Giving birth in a shelter in Israel
-
Five things to know about the planned Iran-US talks in Islamabad
-
Slot feels 'complete support' from Liverpool chiefs despite slump
-
Kyiv books tentative diplomatic coup with Iran war forays
-
Teenager shines as Britain seize control of BJK Cup tie with Australia
-
Chinese, Taiwanese will unite, Xi tells Taiwan opposition leader
-
Sleepy seal diverts traffic in Australian seaside town
-
Artemis astronauts to shed light on space health risks
-
Pakistan prepares to host US-Iran talks, as Lebanon fighting continues
-
Vaccine gaps fuel Bangladesh's deadly measles crisis
-
Fish furore fuels fierce election in India's West Bengal
-
Coachella kicks off with headliners Sabrina Carpenter, Bieber and Karol G
-
Myanmar junta chief sworn in as president
-
Exiled cartoonists give voice to Iran's silenced millions
-
In Pakistan's mediation to end Mideast war, China may hold the key
-
Knicks stay in hunt with late win over rival Celtics
-
'Sartorial diplomacy' on show in expo of late UK queen's fashion
-
Former Japan and AC Milan star Honda laces up boots again at 39
-
Stocks rally on optimism over Iran war ceasefire, oil extends gains
-
Lego-style memes troll Trump after fragile US-Iran truce
-
Chinese slimmers trade lost fat for beef
-
Jackson biopic shows franchise thriving despite abuse claims
-
New Jersey city spurns data center as defiance spreads
-
US box office looking good as cinema owners gather: industry chief
-
Firm Masters greens make life hard on golf's finest
-
GMV Minerals Announces Drill Mobilization at the Mexican Hat Gold Deposit in S.E. Arizona
-
Gamma Resources Adopts Semi-Annual Financial Reporting
-
Defending champ McIlroy shares Masters lead after back-nine birdie run
-
After oil, Venezuela opens up mining to private investors
-
Tigers' Meadows in hospital after colliding with teammate
-
US to host Israel-Lebanon talks as strikes threaten Iran ceasefire
-
'Scrappy' McIlroy leans on experience for share of Masters lead
-
Ukraine and Russia will cease fire for Orthodox Easter
-
Mateta inspires Palace win over Fiorentina in Conference League
-
Pioneering US hip-hop artist Afrika Bambaataa dies at 68
-
Russia bans Nobel-winning rights group, raids independent newspaper, in one day
-
Pentagon denies giving Vatican envoy 'bitter lecture'
-
Watkins propels Villa towards Europa League semis, Forest hold Porto
-
Aston Villa on verge of Europa League semis after beating Bologna
-
Venezuela police clash with protesters demanding salary rises
-
CAF president rejects corruption claims by Senegal
-
Israel and Lebanon set for ceasefire talks next week, says US official
-
US stocks extend gains, shrugging off ceasefire worries
-
IMF chief urges nations to 'do no harm' in fiscal response to Iran war
-
Sixers' Embiid to have surgery for appendicitis - team
-
Russian police raid independent Novaya Gazeta outlet, reporter detained
-
Former heavyweight king Fury adamant 'I've still got it' as Makhmudov awaits
ALT5 Sigma Adds the Official $TRUMP Coin to Its Trading and Payment Platforms
ALT5 Pay Merchants can now accept $TRUMP for payments, with seamless USD or stablecoin conversion.
LAS VEGAS, NV / ACCESS Newswire / February 18, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS), a leading fintech innovator specializing in blockchain-powered solutions, today announced that the Official $TRUMP Coin has been added to both its ALT5 Prime trading platform and to ALT5 Pay, a cutting-edge cryptocurrency payment platform designed for global merchants.
The $TRUMP Coin, launched on January 17, 2025 on the Solana blockchain, has achieved a fully diluted market capitalization of $17 billion and over $2 billion in daily trading liquidity as of February 17, 20251. By adding $TRUMP to its platforms, ALT5 Sigma is enabling a broad range of investors and businesses to engage with the coin through secure, seamless transactions.
ALT5 Pay, which provides global merchants with the ability to accept cryptocurrency payments, now includes the option for merchants to accept $TRUMP Coin. To further enhance the user experience and reduce the inherent volatility risks associated with cryptocurrency payments, merchants using ALT5 Pay can also choose to automatically convert $TRUMP transactions into USD, a stablecoin, or simply accept the $TRUMP as payment, ensuring a stable, predictable value for payments processed through the platform. This integration empowers merchants worldwide to broaden their customer base and tap into the growing number of consumers using cryptocurrency as a preferred method of payment.
"Cryptocurrency has evolved beyond speculation or simply being a store of wealth. It is increasingly being recognized for its real-world utility and as an effective medium of exchange," said Peter Tassiopoulos, CEO of ALT5 Sigma Corporation. "By adding $TRUMP to our platforms, we are reinforcing our commitment to enabling seamless crypto utility across various sectors. Whether for investors, merchants, or consumers, we are creating an ecosystem that fosters efficiency, security, and growth. ALT5 Sigma remains committed to driving the future of finance and paving the way for a world where digital assets are just as easy to use and spend as traditional money."
The addition of $TRUMP Coin also aligns with ALT5 Sigma's broader vision of bridging the gap between the traditional financial system and emerging blockchain technologies. With increasing adoption of cryptocurrencies globally, the demand for solutions that integrate digital assets into everyday transactions is growing rapidly. ALT5 Prime provides traders with advanced tools to buy, sell, and trade $TRUMP and other major digital assets with ease, while ALT5 Pay gives merchants the ability to diversify their payment acceptance options, making the transition to digital currencies as smooth as possible.
About ALT5 Sigma Corporation
ALT5 Sigma Corporation (NASDAQ:ALTS) is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. The Company is one of the constituents of the Russell Microcap Index, as of June 28, 2024.
Launched in 2018, ALT5 Sigma, Inc. (a wholly owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next-generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma, Inc., through its subsidiaries, offers two main platforms to its customers: "ALT5 Pay" and "ALT5 Prime." ALT5 Sigma Inc. processed over $2 billion USD in cryptocurrency transactions in 2024.
ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency(s) automatically or to receive their payment in digital assets.
ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.
1Source: CoinMarketCap
Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5's platforms and business that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion. This press release also may contain statements or links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as "continue", "expect", "intend", "will", "hope", "should", "would", "may", "potential", and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies.
Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled "Risk Factors" in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.
Contact Information
Media/Investor Relations
[email protected]
1-800-400-2247
SOURCE: ALT5 Sigma Corp
View the original press release on ACCESS Newswire
E.Hall--AT